Oncotype Dx: Predicting Breast Cancer Recurrence Risk
The Oncotype DX Breast Cancer Recurrence Score is a genomic test that predicts the likelihood of breast cancer recurrence in patients with early-stage, hormone receptor-positive, HER2-negative breast cancer. It helps guide treatment decisions by providing an individualized risk assessment, estimating the benefit of adjuvant chemotherapy beyond standard hormonal therapy. The test analyzes 21 genes related…